Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.
Access type 1 diabetes specialists in Pittsburgh at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 1 diabetes treatment provided free
This study will evaluate the safety, efficacy and durability of SR-02 administered to the omentum of patients of Type 1 diabetes with severe recurrent hypoglycemia. The study will also help establish the optimal treatment dose. Although this study is open to patients with all HLA or blood types, immunosuppression to prevent rejection will be required in this first in human study.
Sponsor: Seraxis
Check if you qualify for this type 1 diabetes clinical trial in Pittsburgh, PA
If you're searching for type 1 diabetes treatment options in Pittsburgh, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.